Detalhe da pesquisa
1.
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Ann Oncol
; 34(3): 289-299, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494006
2.
The CHASIT study: sequential chemo-immunotherapy in patients with locally advanced urothelial cancer - a non-randomized phase II clinical trial.
BMC Cancer
; 23(1): 539, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312054
3.
Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
Int J Cancer
; 144(6): 1453-1459, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155893
4.
Novel treatment options in the management of metastatic castration-naïve prostate cancer; which treatment modality to choose?
Ann Oncol
; 30(10): 1591-1600, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340031
5.
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.
Ann Oncol
; 30(6): 970-976, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050707
6.
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
Ann Oncol
; 28(7): 1517-1522, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419193
7.
Outcomes of treatment choices in poor prognosis prostate cancer: not against all odds.
Ann Oncol
; 32(7): 831-832, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930524
8.
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.
Pharmacogenomics J
; 16(6): 519-524, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26345519
9.
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
Ann Oncol
; 26(4): 743-749, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25515657
10.
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Ann Oncol
; 26(5): 833-838, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25378299
11.
Linking the lytic and lysogenic bacteriophage cycles to environmental conditions, host physiology and their variability in coastal lagoons.
Environ Microbiol
; 15(9): 2463-75, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23581698
12.
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Ann Oncol
; 24(4): 878-88, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23152360
13.
Scaffold-based tissue engineering: Supercritical carbon dioxide as an alternative method for decellularization and sterilization of dense materials.
Acta Biomater
; 155: 323-332, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423818
14.
Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Br J Cancer
; 107(9): 1637-43, 2012 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23059747
15.
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
ESMO Open
; 7(2): 100416, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248823
16.
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).
Ann Oncol
; 22(5): 1054-1061, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21059637
17.
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.
Prostate Cancer Prostatic Dis
; 24(3): 871-879, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33746212
18.
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study.
ESMO Open
; 6(5): 100241, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34450475
19.
The Dutch nationwide trauma registry: The value of capturing all acute trauma admissions.
Injury
; 51(11): 2553-2559, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32792157
20.
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer.
Br J Cancer
; 100(1): 13-8, 2009 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088719